search
homeHome
exploreDashboard
bookmark_borderBookmarks
show_chartPortfolios
searchExplorerarrow_drop_downFunds
Equities
library_booksLibrary
rss_feedInsights
linkPinindices
smartphoneMobilearrow_drop_downApp Store
Android
  • Dashboardchevron_right

Generics

Pharma Generics

Pharma Generics

1.9%
list of 8 components

Diverging strategies of generic pharmaceutical companies

Pininvest Analysis on Health Care • Mar 18, 2018

Economies of scale in the production of generics through acquisitions may have been tactical responses in the industry, but TEVA's travails throw unforgiving light on on diverging worldwide strategies

© 2026 Marwodis. All rights reserved.
  • Terms of Service
  • Privacy Policy
  • Data Providers